Showing 1221-1230 of 9374 results for "".
Drug Prices Soar, Amgen Files BLA for Biosimilar to Humira
https://practicaldermatology.com/topics/practice-management/dermwiretv-drug-prices-soar-amgen-files-bla-for-biosimilar-to-humira/18672/In this edition, Amgen Submits ABP 501—first Adalimumab biosimilar; prices for dermatology drugs jump and a survey explores patient knowledge of antibiotic resistance. Also, Almirall acquires Veltin from Sitefel/GSK.Aesthetic Combinations: Recent Advancements
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/aesthetic-combinations-recent-advancements/18882/Greg Buford, MD discusses advancements in aesthetic practice, including the most popular interventions among patients and his favorite approaches to patient management.DASIL and the ASDS
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/dasil-and-the-asds/19054/A new partnership between DASIL and the ASDS is intended to improve and expand education for dermatologists and cosmetic surgeons. Michael H. Gold, MD explains.New Analysis of Benzene Contamination in BPO Products
https://practicaldermatology.com/series/dermwire-tv/new-analysis-benzene-contamination-bpo-products/29074/In this week's DermwireTV, new data continues to raise concerns about benzene contamination in BPO products; the FDA expands the approved dosage for Ameluz for actinic keratosis (AK); and in our PA Perspectives segment, Andrew Mastro discusses how to approach a contract negotiation.Hair Loss in Patients With Diverse Skin Tones (Part 2)
https://practicaldermatology.com/programs/practical-dermatology/hair-loss-in-patients-with-diverse-skin-tones-part-2/18195/In this second installment of a two-part episode of The Practical Dermatology Podcast, Brooke Jackson, MD, founder and owner of Skin Wellness Dermatology Associates in Durham, NC, and a dermatologic surgeon and dermatologist, continues the conversation, focusing on different hair textures and stylesDWTV Extra: Phase 3 Data on Roflumilast for AD, PsO
https://practicaldermatology.com/programs/practical-dermatology/dwtv-extra-phase-3-data-on-roflumilast-for-ad-pso/35925/Study investigator Melinda Gooderham, MD, talks about the Phase 3 trials of roflumilast cream 0.15% for adults and children down to age 6 with atopic dermatitis and roflumilast foam 0.3% for patients older than 12 with psoriasis of the scalp and body.Addressing Skin Changes During Menopause: An Update
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/addressing-skin-changes-during-menopause-an-update/20220/New York City-based dermatologist Ellen Gendler, MD, shares pearls from her recent talk at the 2023 annual meeting of the Menopause Society including the current thinking on how to address the effects of diminished estrogen on skin.Dupilumab's Impact on Height, 40-GEP for HNcSCC Lead Posters at Maui Derm
https://practicaldermatology.com/programs/practical-dermatology/dupilumabs-impact-on-height-40-gep-for-hncscc-lead-posters-at-maui-derm/32916/The impact of dupilumab on children’s height and the 40-gene expression profile (40-GEP) test for patients with cutaneous squamous cell carcinoma of the head and neck (HNcSCC) were the topics of the top two posters in the “Late Breakers 2025” session at Maui Derm 2025 in Maui, Hawaii.Acne and Rosacea: Dr. Baldwin
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/acne-and-rosacea-dr-baldwin/32693/Hilary Baldwin, MD, talks about a topic that she did not have time to cover during "Update 2025: Acne and Rosacea" at Maui Derm 2025—emergency contraception in patients on isotretinoin.Articles, Approvals, and Updates of 2023
https://practicaldermatology.com/topics/skin-cancer-photoprotection/articles-approvals-and-updates-of-2023/20231/Daniel Schlessinger, MD, provides his review of some of the year's most important articles, approvals, and updates, and describes how they relate to skin cancers, the first topical gene therapy, hidradenitis suppurativa treatment, and iPledge updates.